{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:07Z","timestamp":1747181107646,"version":"3.40.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Adenoid cystic carcinoma (ACC) of orbit is a very rare epithelial tumor, often originating from the lacrimal glands. At the same time, treatment options are currently limited, such as radiation, chemotherapy. We report a case of a patient treated with antirotinib combined with radiotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 13-year-old girl was initially admitted with \u201cleft eye swelling for over half a year, 12 days after surgery for left orbital adenoid cystic carcinoma\u201d. Initial swelling of the lateral upper eyelid of the left eye, with gradual enlargement and occasional pain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Left orbital adenoid cystic carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>After diagnosis of orbital ACC, she underwent resection of the left orbital mass, and received 33 times of adjuvant radiotherapy, but brain metastases appeared later. She refused further treatment, and received 25 times of radiotherapy and anlotinib therapy after the disease progressed again.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Now the patient has been followed up for 8 months, but no progress was found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Based on this, we hypothesized that radiation therapy in combination with anlotinib is effective for ACC or ACC metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034544","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:03:14Z","timestamp":1693602194000},"page":"e34544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Orbital adenoid cystic carcinoma treated by radiotherapy combined with anlotinib in a 13-year-old girl: A case report"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2242-5206","authenticated-orcid":false,"given":"Xue","family":"Wu","sequence":"first","affiliation":[{"name":"Clinical Medical College of Jining Medical University, Jining, Shandong Province, China"},{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Shandong First Medical University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Shandong First Medical University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Shandong First Medical University, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shu","sequence":"additional","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jining, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Shandong First Medical University, Changsha, China"},{"name":"Cheeloo College of Medicine, Shandong University Jining, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"107623","DOI":"10.1016\/j.ijscr.2022.107623","article-title":"Adenoid cystic carcinoma of the orbit with bilateral cavernous sinus extension: a case report.","volume":"99","author":"Al Ghulaiga","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"R2-20250504","first-page":"963","article-title":"[Prognosis of adenoid cystic carcinoma of head and neck and risk factors for lung metastasis].","volume":"57","author":"Wang","year":"2022","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.21037\/tcr-21-2433","article-title":"Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study.","volume":"11","author":"Su","year":"2022","journal-title":"Transl Cancer Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/cas.13536","article-title":"Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.","volume":"109","author":"Xie","year":"2018","journal-title":"Cancer Sci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/igc.0000000000001129","article-title":"Endometrial cancers harboring mutated fibroblast growth factor receptor 2 protein are successfully treated with a new small tyrosine kinase inhibitor in an orthotopic mouse model.","volume":"28","author":"Taurin","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-17-3766","article-title":"Safety and efficacy of anlotinib, a multikinase angiogenesis inhibitor, in patients with refractory metastatic soft-tissue sarcoma.","volume":"24","author":"Chi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/bjc.2017.478","article-title":"Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).","volume":"118","author":"Han","year":"2018","journal-title":"Br J Cancer"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"103792","DOI":"10.1016\/j.critrevonc.2022.103792","article-title":"Adenoid cystic carcinoma from the salivary and lacrimal glands and the breast: different clinical outcomes to the same tumor.","volume":"179","author":"Emerick","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.116.12.1673","article-title":"Adenoid cystic carcinoma of the lacrimal gland simulating a dermoid cyst in a 9-year-old boy.","volume":"116","author":"Shields","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5693\/djo.02.2018.01.001","article-title":"Adenoid cystic carcinoma presenting with bilateral orbital extension from the soft palate.","volume":"24","author":"Schwartz","year":"2018","journal-title":"Digit J Ophthalmol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/oncotarget.26558","article-title":"Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland.","volume":"10","author":"Doddapaneni","year":"2019","journal-title":"Oncotarget"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e0131689","DOI":"10.1371\/journal.pone.0131689","article-title":"Expression of Notch1 correlates with breast cancer progression and prognosis.","volume":"10","author":"Yuan","year":"2015","journal-title":"PLoS One"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e1467","DOI":"10.1111\/aos.14812","article-title":"Prognostic impact of Notch1 receptor and clinicopathological high-risk predictors in lacrimal gland adenoid cystic carcinoma.","volume":"99","author":"Anjum","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2147\/CMAR.S355663","article-title":"Beyond surgical treatment in adenoid cystic carcinoma of the head and neck: a literature review.","volume":"14","author":"Atallah","year":"2022","journal-title":"Cancer Manag Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.blre.2020.100672","article-title":"Targeting MCL-1 in hematologic malignancies: rationale and progress.","volume":"44","author":"Wei","year":"2020","journal-title":"Blood Rev"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.4049\/jimmunol.1801650","article-title":"Notch signaling controls transcription via the recruitment of RUNX1 and MYB to enhancers during T cell development.","volume":"202","author":"Rodr\u00edguez-Caparr\u00f3s","year":"2019","journal-title":"J Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:11:13Z","timestamp":1746324673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":17,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034544","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}